首页 | 本学科首页   官方微博 | 高级检索  
     

自制双通道内镜及扩张器辅以抗癌药物治疗晚期癌性幽门梗阻——附13例报告
引用本文:余小宝 胡衍菊. 自制双通道内镜及扩张器辅以抗癌药物治疗晚期癌性幽门梗阻——附13例报告[J]. 航空航天医药, 1994, 5(1): 8-10
作者姓名:余小宝 胡衍菊
作者单位:[1]江西省南昌334医院内三科 [2]江西省奉新县人民医院内镜室
摘    要:介绍了双通道内镜及内镜用扩张器的制作方法及采用上述器械在内镜直视下对晚期癌性幽门梗阻进行扩张再通的方法,并将接受扩张及局部注射抗癌治疗的患者与同期同类接受手术及全身化疗的患者预后进行随访对比,结果表明,扩张及局部化疗患者的平均存活时间为7.7个月,手术及全身化疗患者的平均存活时间为7.9个月(P>0.5);治疗费用前者远低于后者(P<0.001);开始进食时间前者优于后者,生命质量两者相似,认为本方法是一种较实用的解除梗阻,延长生命的方法。

关 键 词:癌性 幽门梗阻 双通道内镜 扩张器 药物疗法

THE DOUBLE PASSAGE ENDOSCOPE AND DLLATORWASMADE WITH ONESELF SUPPLEMENTARY DRUGCANCERFIGIITING TREATMENTCANCEROUS PYLORISTENOSIS
Yu Xiao-bao et al. THE DOUBLE PASSAGE ENDOSCOPE AND DLLATORWASMADE WITH ONESELF SUPPLEMENTARY DRUGCANCERFIGIITING TREATMENTCANCEROUS PYLORISTENOSIS[J]. Aerospace Medicine, 1994, 5(1): 8-10
Authors:Yu Xiao-bao et al
Affiliation:334 hospital of Nan Chang
Abstract:in this article it is introduced the preparation of double passage endoscope and endoscope dilation, and how louse such instruments to expandand, unobstruet agan to the late cancerous pyloristenosis, By the follow up sarvey comparsionof the prignosis between the patients who accept the cure with dilatation andlocalchemotherapy and who accept the treatment with genernal chemotherapy and operation during the same kinds people at the same time it is shoull that the average surlyal time of the former patient is 7. 7 months, and that of the latter is 7. 9 months,the last in the formar treatment is much more lower than that in the latter, the living quality of the former patient is the same as the atter the former time of beginingto eat, is suprion to the latter. It is recognired that the former treatment is a practical mach to release obstruction, prolong living.
Keywords:cancerous pyloristenosis  double passage endoscope  dilator  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号